+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

International Innovation Grant

Conquer Cancer Foundation of ASCO

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each grant or award type. The Committee scores and ranks the applications, and the highest-scoring applications are funded.

In some circumstances, applications already deemed "fundable" based on their high application scores may be matched with Conquer Cancer grants that have additional donor-specified criteria. However, all fundable applications will receive Conquer Cancer research grants. In no case will an application not deemed fundable in the initial review process receive a Conquer Cancer research grant.

The International Innovation Grant (IIG) provides research funding in support of novel and innovative projects that can have a significant impact on cancer control in low- and middle-income countries (LMCs). It is intended to support proposals that have the potential to reduce the cancer burden in local communities, while also being potentially transferable to other low- or middle-income settings.

The IIG is a two-step application process that includes both a Letter of Intent (LOI) and a full proposal. After LOI reviews, LOIs that meet the eligibility criteria and that fit within the research project criteria will be invited for a full application submission.

Funding Available

The IIG is a one-year research grant of up to $20,000 that is awarded and paid directly to a nonprofit organization or governmental agency (“Grantee Organization”) in a low-income or middle-income country. The number of IIGs in each funding cycle is not predetermined by Conquer Cancer. Conquer Cancer is committed to funding the most meritorious applications in all areas of cancer research.

AI Based Application Success Predictor

1. Clinical and Translational Relevance — Not Just Basic Biology

Conquer Cancer emphasizes clinical/translational oncology research, not purely basic lab work. For example, their Career Development Awards require “patient-oriented focus, including clinical research and/or translational research involving human subjects.”

Proposals with immediate or near-term potential to change patient care, treatment protocols, biomarker use, or survivorship outcomes tend to perform better than those with purely theoretical aims.

Predictor: Projects must have a clear pathway from bench to bedside or directly improve care.

2. Addressing Unmet Needs / High-Impact Questions

Conquer Cancer favors applications tackling gaps in clinical care, disparities, toxicity reduction, survivorship, under-served populations, or rare/less-studied cancers.

Proposals that articulate “why now?” — urgency, unmet clinical needs, lack of existing data — generally stand out more.

Predictor: If your project addresses a clear unmet need (e.g. health equity, toxicity reduction, rare cancers), it’s more competitive.

3. Feasible, Well-Designed Clinical or Translational Study with Realistic Aims

Because many Conquer Cancer awards are short (1–2 years) or modestly funded, applications with focused aims (2–3), clearly defined endpoints, realistic enrollment or sample size, and rigorous biostatistics plans score much higher.

Overly ambitious or overly broad proposals (e.g. “multi-omics, big cohort, long follow-up”) tend to underperform.

Predictor: A tight, realistic project design with clear deliverables is strongly favored.

4. Strong Investigator Profile & Well-Designed Mentorship / Training (for Early-Career Awards)

For YIA and CDA, Conquer Cancer expects candidates to be in transition (fellowship → faculty, or early independent faculty) and able to demonstrate potential for independence — not just as mentees.

Having a distinct niche (so you’re not “more of the same” as your mentor), protected research time, and a clear plan for career development and future funding is critical.

Predictor: Reviewers trust candidates with a strong track record + clear future direction + adequate mentorship plan.

5. Access to Real-World Patients / Cohorts or Clinical Infrastructure

High-scoring translational or clinical proposals often show ready access to patient populations, clinical databases, biospecimens, or multi-site collaborations — things that can enable rapid accrual and meaningful endpoints.

Conquer Cancer also supports global and international collaborations, widening eligibility beyond U.S. borders.

Predictor: Demonstrated clinical feasibility and patient access improves success.

6. Emphasis on Quality of Life, Survivorship, Equity, and Health Disparities (Where Relevant)

Proposals focusing on toxicity reduction, survivorship care, psychosocial outcomes, access to care, and addressing disparities are increasingly favored.

Especially in implementation-oriented or real-world research grants, this patient-centered focus aligns well with Conquer Cancer’s mission.

Predictor: Projects with patient-centered outcomes beyond just survival are competitive, especially under care/outcomes-focused calls.

7. Strong Scientific Rigor & Statistical/Methodologic Soundness

The review process includes scientific reviewers + biostatistics reviewers + (for clinical proposals) patient-advocate reviewers.

A sound statistical plan, realistic sampling, and well-defined outcome measures are essential. Weak methodology is a common flaw flagged by reviewers.

Predictor: High methodological quality and reproducibility planning strongly influence scoring.

8. Focused Budgets and Efficient Use of Funding

Since many Conquer Cancer grants are modest or short-term, proposals that show efficient, well-justified budgets — especially non-personnel costs and limited complexity — are viewed more favorably.

Overly ambitious budget or excessive equipment requests without justification tend to get down-scored.

Predictor: Transparent, realistic budgeting improves likelihood of funding.

9. Diversity, Equity, and Global/International Relevance (for appropriate mechanisms)

Conquer Cancer supports global oncology efforts, and many grants recognize the importance of racial/ethnic diversity, geographic access, underrepresented populations, and global equity in cancer care & research.

Proposals that address disparities in cancer care or access, or include underserved populations, often have additional merit.

Predictor: Well-justified inclusion of equity and global health aspects adds value, especially in global/international or health services–oriented proposals.

10. Realistic Career Development — Not “R01-Scale” Projects

For early-career grants, Conquer Cancer expects projects that are feasible within 1–2 years and modest budgets, with intention to generate data for larger future grants.

Reviewers penalize proposals that attempt to do too much or over-commit resources in a short timeframe.

Predictor: Projects that view funding as a stepping stone, not the “end goal,” tend to perform better.

🎯 What This Means Strategically — If You’re Applying to Conquer Cancer

Design your proposal around translational or clinical impact, with clear patient-centered goals.

Keep aims tight, deliverable, and achievable within the grant period.

Show strong methodological planning, real access to patients or specimens, and rigor.

For early-career grants — emphasize mentorship, protected time, and career trajectory, not just a one-off project.

Include health-equity or survivorship considerations where relevant.

Use a lean, justified budget.

Position the grant as a foundation for future work, not a final product.

Specialties

Cancer

Oncology

Eligibility Requirements

All of the following criteria must be met in order to qualify for an IIG:

Applicant Organization:

Must be an organization with a charitable purpose registered as a not-for-profit with the relevant national authority or must be a government agency. This organization will administer the grant funds for the sole purpose of the project. Examples of potential not-for-profit organizations are medical societies or associations, advocacy organizations, foundations, hospitals, and universities.
Must be located in a country categorized by the World Bank as Low-Income, Lower-Middle Income, or Upper-Middle Income.
Must have been operating for at least one full year, have an acceptable management structure and processes in place, and be solvent with or without the support of the International Innovation Grant.
Should have experience in carrying out activities with tangible outcomes.

Principal Investigator:

Must be a member of ASCO (any membership category) or have submitted a membership application with the grant application.
Must be a citizen or permanent resident of a country defined by the World Bank as Low-Income, Lower-Middle Income, or Upper-Middle Income, and currently residing in that country.
Must be affiliated with the applicant organization.

For 2026, dedicated funding is available in, but not limited to, the areas listed below. This list will be updated as new funding is confirmed.

Sponsor Details

Sponsor Institute/Organizations: Conquer Cancer Foundation of ASCO

Sponsor Type: Corporate/Non-Profit

Address: 2318 Mill Road, Suite 800 | Alexandria, VA 22314

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity